Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



SCHOEMAKER KATHLEEN K Create: Alert

All | News | Filings
Date FiledTypeDescription
08/20/2015 4 DP VII ASSOCIATES LP (10% Owner) has filed a Form 4 on Evoke Pharma Inc
Txns: Sold 202 shares @ $7.02, valued at $1.4k
08/20/2015 4 DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on Evoke Pharma Inc
Txns: Sold 11,836 shares @ $7.02, valued at $83.1k
07/01/2015 4 Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on GLAUKOS Corp
Txns: Converted 876,083 shares @ $0
Converted 589,100 preferred shares @ $0
Converted 286,983 preferred shares @ $0
07/01/2015 4 DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on GLAUKOS Corp
Txns: Converted 6,501 shares @ $0
Converted 4,371 preferred shares @ $0
Converted 2,130 preferred shares @ $0
07/01/2015 4 DOMAIN PARTNERS IV LP (10% Owner) has filed a Form 4 on GLAUKOS Corp
Txns: Converted 2,057,190 shares @ $0
Paid exercise price by delivering 8,700 shares @ $18, valued at $156.6k
Converted 585,958 preferred shares @ $0
Converted 925,926 preferred shares @ $0
Converted 440,178 preferred shares @ $0
Converted 105,128 preferred shares @ $0
Exercised 20,470 warrants @ $7.65, valued at $156.6k
07/01/2015 4 DP IV ASSOCIATES LP (10% Owner) has filed a Form 4 on GLAUKOS Corp
Txns: Converted 14,041 shares @ $0
Converted 14,041 preferred shares @ $0
05/12/2015 4 DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on aTYR PHARMA INC
Txns: Converted 13,414 shares @ $0
Converted 90,110 preferred shares @ $0
Converted 11,182 preferred shares @ $0
Converted 6,581 preferred shares @ $0
05/12/2015 4 Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on aTYR PHARMA INC
Txns: Converted 1,807,820 shares @ $0
Converted 12,143,933 preferred shares @ $0
Converted 1,506,901 preferred shares @ $0
Converted 887,073 preferred shares @ $0
05/11/2015 4 DP VI Associates, L.P. (10% Owner) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.
Txns: Converted 3,519 shares @ $0
Converted 1,954 preferred shares @ $0
Converted 1,565 preferred shares @ $0
05/11/2015 4 Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.
Txns: Converted 2,202,233 shares @ $0
Converted 798,188 preferred shares @ $0
Converted 939,289 preferred shares @ $0
Converted 464,756 preferred shares @ $0
05/06/2015 4 DOMAIN ASSOCIATES (10% Owner) has filed a Form 4 on Tibira Therapeutics, Inc.
Txns: Acquired 36,187 shares @ $0
05/06/2015 4 DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on Regado Biosciences Inc
Txns: Bought 277,777 shares @ $10.62, valued at $2.9M
04/16/2015 4 DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on Evoke Pharma Inc
Txns: Sold 9,832 shares @ $7.78, valued at $76.5k
Sold 7,920 shares @ $7.58, valued at $60k
Sold 32,411 shares @ $7.07, valued at $229.1k
04/16/2015 4 DP VII ASSOCIATES LP (10% Owner) has filed a Form 4 on Evoke Pharma Inc
Txns: Sold 168 shares @ $7.78, valued at $1.3k
Sold 135 shares @ $7.58, valued at $1k
Sold 554 shares @ $7.07, valued at $3.9k
03/24/2015 4 DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Disposed of 350,000 shares @ $0
11/26/2014 4 DP VII ASSOCIATES LP (10% Owner) has filed a Form 4 on Neothetics, Inc.
Txns: Converted 46,309 shares @ $0
Paid exercise price by delivering 958 shares @ $14, valued at $13.4k
Paid exercise price by delivering 1,725 shares @ $14, valued at $24.2k
Converted 12,578 preferred shares @ $0
Converted 104,247 preferred shares @ $0
Converted 36,913 preferred shares @ $0
Converted 102,282 preferred shares @ $0
Exercised 1,570 options to buy @ $8.54, valued at $13.4k
Exercised 2,827 options to buy @ $8.54, valued at $24.1k
11/26/2014 4 DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on Neothetics, Inc.
Txns: Converted 2,921,064 shares @ $0
Paid exercise price by delivering 56,185 shares @ $14, valued at $786.6k
Paid exercise price by delivering 101,132 shares @ $14, valued at $1.4M
Bought 70,000 shares @ $14, valued at $980k
Converted 737,422 preferred shares @ $0
Converted 6,111,968 preferred shares @ $0
Converted 2,164,305 preferred shares @ $0
Converted 7,252,144 preferred shares @ $0
Exercised 92,105 options to buy @ $8.54, valued at $786.6k
Exercised 165,790 options to buy @ $8.54, valued at $1.4M
11/18/2014 4 Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
Txns: Disposed/sold 3,006,132 shares @ $0
Disposed/sold 3,006,132 shares @ $0
11/18/2014 4 DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
Txns: Disposed/sold 22,306 shares @ $0
11/18/2014 4 DOMAIN ASSOCIATES (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
Txns: Disposed/sold 6,250 shares @ $0
10/21/2014 4 DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Bought 500,000 shares @ $20, valued at $10M
10/21/2014 4 DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Converted 14,049 shares @ $0
Bought 1,841 shares @ $11, valued at $20.3k
Converted 9,443 preferred shares @ $0
Converted 4,606 preferred shares @ $0
10/21/2014 4 Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Converted 1,893,383 shares @ $0
Bought 248,159 shares @ $11, valued at $2.7M
Converted 1,272,607 preferred shares @ $0
Converted 620,776 preferred shares @ $0
09/12/2014 4 Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on VERACYTE, INC.
Txns: Disposed of 300,000 shares @ $0
08/18/2014 4 DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on Otonomy, Inc.
Txns: Converted 11,490 shares @ $0
Paid exercise price by delivering 277 shares @ $16, valued at $4.4k
Converted 3,238 preferred shares @ $0
Converted 6,866 preferred shares @ $0
Paid exercise price by delivering 1,386 preferred shares @ $0
Exercised 502 options to buy @ $8.79, valued at $4.4k
08/18/2014 4 Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Otonomy, Inc.
Txns: Converted 1,548,792 shares @ $0
Paid exercise price by delivering 37,224 shares @ $16, valued at $595.6k
Converted 436,485 preferred shares @ $0
Converted 925,479 preferred shares @ $0
Paid exercise price by delivering 186,828 preferred shares @ $0
Exercised 67,755 options to buy @ $8.79, valued at $595.6k
08/07/2014 4 DP VI Associates, L.P. (10% Owner) has filed a Form 4 on MARINUS PHARMACEUTICALS INC
Txns: Converted 17,000 shares @ $0
Converted 8,792 preferred shares @ $0
Converted 7,043 preferred shares @ $0
Converted 1,165 preferred shares @ $0
08/07/2014 4 Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on MARINUS PHARMACEUTICALS INC
Txns: Converted 2,057,142 shares @ $0
Bought 419,744 shares @ $8, valued at $3.4M
Converted 820,320 preferred shares @ $0
Converted 657,192 preferred shares @ $0
Converted 579,630 preferred shares @ $0
05/07/2014 4 Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on Aldeyra Therapeutics, Inc.
Txns: Converted 21,250 shares @ $0
Converted convertible notes @ $8, valued at $0
05/05/2014 4 DP VI Associates, L.P. (10% Owner) has filed a Form 4 on Aldeyra Therapeutics, Inc.
Txns: Converted 9,208 shares @ $0
Converted 3,882 preferred shares @ $0
05/05/2014 4 Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on Aldeyra Therapeutics, Inc.
Txns: Converted 1,909,113 shares @ $0
Paid exercise price by delivering 39,063 shares @ $8, valued at $312.5k
Converted 486,316 preferred shares @ $0
Converted 755,263 preferred shares @ $0
Exercised 60,576 options to buy @ $5.16, valued at $312.6k
03/21/2014 4 SCHOEMAKER KATHLEEN K (10% Owner) has filed a Form 4 on CADENCE PHARMACEUTICALS INC
Txns: Disposed/sold 2,972,678 shares @ $14, valued at $41.6M
Disposed/sold 50,743 shares @ $14, valued at $710.4k
Disposed/sold 7,313,241 shares @ $14, valued at $102.4M
Disposed/sold 78,369 shares @ $14, valued at $1.1M
Disposed/sold 27,500 shares @ $14, valued at $385k
03/17/2014 4 SCHOEMAKER KATHLEEN K (10% Owner) has filed a Form 4 on Achaogen Inc
Txns: Converted 1,987,049 shares @ $0
Converted 33,890 shares @ $0
Converted 625,065 preferred shares @ $0
Converted 926,321 preferred shares @ $0
Converted 435,663 preferred shares @ $0
Converted 10,661 preferred shares @ $0
Converted 15,799 preferred shares @ $0
Converted 7,430 preferred shares @ $0
02/14/2014 4 DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on CADENCE PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 765,532 shares @ $14, valued at $10.7M
Exercised 1,367,020 options to buy @ $7.84, valued at $10.7M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy